Personal Genome Diagnostics: Mark Sausen
Personal Genome Diagnostics has appointed Mark Sausen as VP of technology innovation. Sausen previously spent six years as VP of research and development at PGDx and returns to the company from a stint as scientific director of clinical genetics and genomics at Bristol Myers Squibb. In his new role at PGDx, Sausen will lead the identification and development of new genomic sequencing technologies and applications to expand the firm's Elio product line.
Among other experience, Sausen has contributed to research at the Ludwig Center for Cancer Genetics and Therapeutics, the Helen F. Graham Cancer Center, and the Human Performance Laboratory. He holds a PhD in cellular and molecular medicine from Johns Hopkins School of Medicine, and has received numerous awards and research grants for his work in genomics and diagnostics.